Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

AZAPERONE CRS (50 MG)

AZAPERONE CRS (50 MG)

1649-18-9

DISCOVER
Salbutamol impurity B CRS, 5mg

Salbutamol impurity B CRS, 5mg

NA

DISCOVER
Salbutamol impurity F CRS, 10mg

Salbutamol impurity F CRS, 10mg

NA

DISCOVER
Salbutamol impurity I CRS, 0.006mg

Salbutamol impurity I CRS, 0.006mg

NA

DISCOVER
CARBAMAZEPINE IMPURITY A CRS (20 MG)

CARBAMAZEPINE IMPURITY A CRS (20 MG)

3564-73-6

DISCOVER
Salbutamol impurity G CRS, 10mg

Salbutamol impurity G CRS, 10mg

24085-08-3

DISCOVER
Carisoprodol CRS, 50mg

Carisoprodol CRS, 50mg

78-44-4

DISCOVER
Carisoprodol impurity A CRS, 10mg

Carisoprodol impurity A CRS, 10mg

NA

DISCOVER
ISOFLURANE - REFERENCE SPECTRUM (N/A)

ISOFLURANE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
PIRENZEPINE DIHYDROCHLORIDE MONOHYDRATE CRS (250 MG)

PIRENZEPINE DIHYDROCHLORIDE MONOHYDRATE CRS (250 MG)

29868-97-1

DISCOVER
SODIUM ASCORBATE CRS (50 MG)

SODIUM ASCORBATE CRS (50 MG)

134-03-2

DISCOVER
CICLOPIROX CRS (75 MG)

CICLOPIROX CRS (75 MG)

29342-05-0

DISCOVER